ES8300763A1 - Un procedimiento para la preparacion de nuevos derivados de 3-(1-piperidemil)alquil-4h-pirido(1,2-a)pirimidin-4-ona. - Google Patents

Un procedimiento para la preparacion de nuevos derivados de 3-(1-piperidemil)alquil-4h-pirido(1,2-a)pirimidin-4-ona.

Info

Publication number
ES8300763A1
ES8300763A1 ES500814A ES500814A ES8300763A1 ES 8300763 A1 ES8300763 A1 ES 8300763A1 ES 500814 A ES500814 A ES 500814A ES 500814 A ES500814 A ES 500814A ES 8300763 A1 ES8300763 A1 ES 8300763A1
Authority
ES
Spain
Prior art keywords
piperidinylalkyl
pyrido
pyrimidin
derivatives
antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES500814A
Other languages
English (en)
Other versions
ES500814A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of ES500814A0 publication Critical patent/ES500814A0/es
Publication of ES8300763A1 publication Critical patent/ES8300763A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE 3-<014>(1-PIPERIDINIL)ALQUIL<015>-4H-PIRIDO<014>1,2-A<015> PIRIMIDIN-4-ONA Y DE SUS SALES DE ADICION DE ACIDO FISIOLOGICAMENTE COMPATIBLES DE FORMULA (I), EN LA QUE ALK ES UN ALQUILENO INFERIOR; AR ES UN ARILO; Y R, R , R , R Y X PUEDEN SER VARIOS TIPOS DE RADICALES. CONSISTE EN LA REACCION DE UN COMPUESTO DE FORMULA (II) CON UN COMPUESTO DE FORMULA (III), EN LAS QUE W ES UN GRUPO ESTER REACTIVO TAL COMO HALOGENO O SULFENILOXI, Y TODOS LOS DEMAS SIMBOLOS TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I). LA REACCION SE LLEVA A CABO EN UN DISOLVENTE ORGANICO INERTE, EN PRESENCIA DE UNA BASE, A LA TEMPERATURA DE REFLUJO. >ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS COMO AGENTES CARDIOVASCULARES.
ES500814A 1980-03-28 1981-03-27 Un procedimiento para la preparacion de nuevos derivados de 3-(1-piperidemil)alquil-4h-pirido(1,2-a)pirimidin-4-ona. Expired ES8300763A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13484580A 1980-03-28 1980-03-28
US06/191,632 US4342870A (en) 1980-03-28 1980-09-29 Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives

Publications (2)

Publication Number Publication Date
ES500814A0 ES500814A0 (es) 1982-11-01
ES8300763A1 true ES8300763A1 (es) 1982-11-01

Family

ID=26832744

Family Applications (1)

Application Number Title Priority Date Filing Date
ES500814A Expired ES8300763A1 (es) 1980-03-28 1981-03-27 Un procedimiento para la preparacion de nuevos derivados de 3-(1-piperidemil)alquil-4h-pirido(1,2-a)pirimidin-4-ona.

Country Status (22)

Country Link
US (1) US4342870A (es)
EP (1) EP0037265B1 (es)
AU (1) AU537700B2 (es)
BG (1) BG36199A3 (es)
CA (1) CA1163994A (es)
CS (1) CS256366B2 (es)
DE (1) DE3168433D1 (es)
DK (1) DK159390C (es)
ES (1) ES8300763A1 (es)
FI (1) FI71737C (es)
GR (1) GR72488B (es)
HU (1) HU187329B (es)
IE (1) IE51319B1 (es)
IL (1) IL62494A (es)
MA (1) MA19107A1 (es)
NO (1) NO156752C (es)
NZ (1) NZ196522A (es)
PH (1) PH16530A (es)
PT (1) PT72740B (es)
RO (1) RO82508A (es)
SU (1) SU1068037A3 (es)
YU (1) YU43010B (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443451A (en) * 1981-07-15 1984-04-17 Janssen Pharmaceutica N.V. Bicyclic pyrimidin-5-one derivatives
US4548938A (en) * 1981-07-15 1985-10-22 Janssen Pharmaceutica N.V. 5-H-1,3,4-thiadiazolo[3,2-a]pyrimidin-5-one compounds
US4355037A (en) * 1981-11-12 1982-10-19 Hoechst-Roussel Pharmaceuticals 3-(4-Piperidyl)-1,2-benzisoxales
US4485107A (en) * 1982-11-01 1984-11-27 Janssen Pharmaceutica N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones
US4581171A (en) * 1983-07-27 1986-04-08 Janssen Pharmaceutica, N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones useful for treating psychotropic disorders
US4888426A (en) * 1983-11-30 1989-12-19 Janssen Pharmaceutica N.V. 1-(5-methyl-furan-2-ylmethyl)-N-(4-piperidinyl)imidazo [4,5-6]pyridine-2-amine
US4695569A (en) * 1983-11-30 1987-09-22 Janssen Pharmaceutica N.V. Bicyclic heterocyclyl containing N-(bicyclic heterocyclyl)-4-piperidinamines
PH23995A (en) * 1984-01-09 1990-02-09 Janssen Pharmaceutica Nv 4((bicycle heterocyclyl)-methyl and hetero)piperidines
US4548939A (en) * 1984-10-01 1985-10-22 Janssen Pharmaceutica N. V. 1H-Indol-3-yl containing 1,3-dimethyl-1H-purine-2,6-diones
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
ES2094718T3 (es) * 1986-09-22 1997-02-01 Janssen Pharmaceutica Nv Antagonistas de la serotonine para el tratamiento de heridas.
IL90879A0 (en) * 1988-09-02 1990-02-09 Janssen Pharmaceutica Nv 3-piperidinyl-indazole derivatives,their preparation and antihypertensive compositions containing them
CA2000786C (en) * 1988-11-07 1999-01-26 Cornelus G. M. Janssen 3-piperidinyl-1,2-benzisoxazoles
WO1990006303A1 (en) * 1988-12-02 1990-06-14 Pfizer Inc. Arylpiperidine derivatives
JPH04504263A (ja) * 1989-03-23 1992-07-30 マリンクロッド・インコーポレイテッド 放射性沃素又は臭素標識ピペリジン化合物、並びに上記化合物の及び上記化合物を含む組成物の製法
DE4138756A1 (de) * 1991-11-26 1993-05-27 Troponwerke Gmbh & Co Kg Kombination mit neuroprotektiver wirkung
US5266571A (en) * 1992-01-09 1993-11-30 Amer Moh Samir Treatment of hemorrhoids with 5-HT2 antagonists
KR100269756B1 (ko) * 1992-02-13 2000-10-16 슈테펜엘.네스비트 피페리디닐티아시클릭유도체(Piperidinyl Thiacyclic Derivatives)
NZ254113A (en) 1992-07-13 1995-08-28 Janssen Pharmaceutica Nv Fused piperidine derivatives and medicaments
JP3645906B2 (ja) * 1993-11-19 2005-05-11 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ マイクロカプセル封入された３−ピペリジニル−置換１，２−ベンズイソオキサゾール類及び１，２−ベンズイソチアゾール類
ES2085234B1 (es) * 1994-02-24 1997-01-16 Vita Invest Sa Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
TW421649B (en) * 1995-01-31 2001-02-11 Janssen Pharmaceutica Nv 4-(1H-indol-1yl)-1-piperidinyl derivatives
US5753664A (en) * 1995-03-16 1998-05-19 Takeda Chemical Industries, Ltd. Heterocyclic compounds, their production and use
EP1560814A1 (en) * 2002-11-13 2005-08-10 Synthon B.V. Process for making risperidone and intermediates therefor
EP1615923A1 (en) * 2003-04-22 2006-01-18 Synthon B.V. Risperidone monohydrochloride
WO2009108798A1 (en) 2008-02-29 2009-09-03 Vm Discovery Inc. Method for treating pain syndrome and other disorders
ES2697174T3 (es) * 2012-02-10 2019-01-22 Ptc Therapeutics Inc Compuestos para tratar atrofia muscular espinal
WO2013130689A1 (en) 2012-03-01 2013-09-06 Ptc Therapeutics, Inc. Compounds for treating spinal muscular atrophy
BR112014023483B1 (pt) 2012-03-23 2022-05-10 Ptc Therapeutics, Inc Composto e seu uso, composição farmacêutica e seu uso
EP2970188A4 (en) * 2013-03-15 2016-10-19 Vm Therapeutics Llc NOVEL CRYSTALLINE FORMS
US10195202B2 (en) 2013-12-19 2019-02-05 Ptc Therapeutics, Inc. Methods for modulating the amount of RNA transcripts
WO2016196386A1 (en) 2015-05-30 2016-12-08 Ptc Therapeutics, Inc. Methods for modulating rna splicing
DK3386511T3 (da) 2015-12-10 2021-07-05 Ptc Therapeutics Inc Fremgangsmåder til behandling af huntingtons sygdom
JP2019535789A (ja) 2016-11-28 2019-12-12 ピーティーシー セラピューティクス，インコーポレーテッド Ｒｎａスプライシングを調節する方法
EP3634953B1 (en) 2017-06-05 2024-01-03 PTC Therapeutics, Inc. Compounds for treating huntington's disease
EA202090034A1 (ru) 2017-06-14 2020-04-16 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Способы модификации сплайсинга рнк
WO2019005980A1 (en) 2017-06-28 2019-01-03 Ptc Therapeutics, Inc. METHODS OF TREATING HUNTINGTON'S DISEASE
EP3645121A4 (en) 2017-06-28 2021-03-17 PTC Therapeutics, Inc. HUNTINGTON'S DISEASE TREATMENT METHODS
BR112020019373A2 (pt) 2018-03-27 2020-12-29 Ptc Therapeutics, Inc. Compostos para o tratamento da doença de hutington
US11685746B2 (en) 2018-06-27 2023-06-27 Ptc Therapeutics, Inc. Heteroaryl compounds for treating Huntington's disease
AU2019294478B2 (en) 2018-06-27 2023-03-23 Ptc Therapeutics, Inc. Heterocyclic and heteroaryl compounds for treating Huntington's disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3412094A (en) * 1967-06-21 1968-11-19 Searle & Co 5-alkyl-2-amino-4-azido-6-phenylpyrimidines and congeners
US3960863A (en) * 1974-06-25 1976-06-01 Sankyo Company Limited Pyrido[1,2-a]pyrimidinone derivatives
JPS5146497A (en) * 1974-10-19 1976-04-20 Masato Aiura Hobuban
JPS525795A (en) * 1975-06-28 1977-01-17 Sankyo Co Ltd Preparation of tetrahydro pyridopyrimidinone derivatives
HU173438B (hu) * 1975-11-27 1979-05-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom

Also Published As

Publication number Publication date
EP0037265A1 (en) 1981-10-07
IE51319B1 (en) 1986-12-10
IE810706L (en) 1981-09-28
GR72488B (es) 1983-11-14
IL62494A0 (en) 1981-05-20
AU537700B2 (en) 1984-07-05
YU43010B (en) 1989-02-28
DK159390B (da) 1990-10-08
YU81081A (en) 1983-12-31
RO82508A (ro) 1983-09-26
FI71737C (fi) 1987-02-09
BG36199A3 (en) 1984-09-14
DE3168433D1 (de) 1985-03-07
DK138281A (da) 1981-09-29
PT72740B (en) 1982-11-16
PH16530A (en) 1983-11-10
NZ196522A (en) 1985-10-11
NO156752B (no) 1987-08-10
ES500814A0 (es) 1982-11-01
CA1163994A (en) 1984-03-20
DK159390C (da) 1991-03-04
SU1068037A3 (ru) 1984-01-15
RO82508B (ro) 1983-08-30
HU187329B (en) 1985-12-28
US4342870A (en) 1982-08-03
AU6842981A (en) 1981-10-01
NO811058L (no) 1981-09-29
FI810956L (fi) 1981-09-29
PT72740A (en) 1981-04-01
IL62494A (en) 1984-08-31
CS256366B2 (en) 1988-04-15
FI71737B (fi) 1986-10-31
MA19107A1 (fr) 1981-10-01
EP0037265B1 (en) 1985-01-23
NO156752C (no) 1987-11-18

Similar Documents

Publication Publication Date Title
ES8300763A1 (es) Un procedimiento para la preparacion de nuevos derivados de 3-(1-piperidemil)alquil-4h-pirido(1,2-a)pirimidin-4-ona.
IE790676L (en) N-heterocyclyl-4-piperidinamines
AU513469B2 (en) Pyrido (2, 1, -b) - quinazoline derivatives
AU518364B2 (en) Pyrido 1, 2 pyrimidine derivatives
ZA812085B (en) Novel 3-(1-piperidinylalkyl)4h-pyrido(1,2-a)pyrimidin-4one derivatives
PH15062A (en) 1-hydroxyalkanamine pyrano (3,4-b)indole derivative
AU516695B2 (en) Heterocyclic substituted imidazo (1, 2-a)pyridines
AU527931B2 (en) Substituted pyrido(1,2-a)pyrimidines
AU611428B2 (en) 3-(substituted(pyrazolo/s-triazolo)(1,5a) pyrimidinylthiomethyl)-7-acyl-cephalosporin derivatives
AU520803B2 (en) Pyrido (1,2-a) pyrimidine derivatives
AU2773184A (en) Spiro(imidazolidine-4,3:-indoline) derivatives
AU543463B2 (en) Tetrahydro-4-thieno(3,2-c)pyridin-2-one derivatives
AU538185B2 (en) Tetrahydrothiopyrano(3,2-b)indole derivatives
AU551160B2 (en) Benzazepino-(4,3,2-ij)pyrazino(1,2-a)quinoline derivatives
AU503851B2 (en) Benzo (1,3) dioxin derivatives
AU546924B2 (en) Indolo(3,2,1-de)(1,5-naphthyridines)
AU539032B2 (en) Furo(3,4-b) pyridin-5-(7)-one derivatives
AU7906381A (en) Tetrahydro-1,2,4-oxadiazin-5-one derivatives
AU534272B2 (en) Pyrido (2,3-e)-as-triazine derivatives
AU5278479A (en) Perhydro-1,3,-thiazine derivatives
AU516587B2 (en) Salts of2,8-dicarboxy-4,6-dioxo-10-propyl-4h,6h-benzo (1,2-b:5,4-b&#39;) dipyran
AU7906581A (en) Tetrahydro-1,2,4-oxadiazin-5-one derivatives
ATE11415T1 (de) 3-(1-piperidinylalkyl)-4h-pyrido(1,2-a)pyrimidi - 4-on-derivate.
AU510553B2 (en) S-Triazolo (3, 4-B) Benzothiazoles
AU4624379A (en) Pyrido(1,2-a)pyrimidines

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519